Arcus Biosciences is Biotechnology in United States that focus on Arcus Biosciences Inc business. Founded in 2015. They cover business area such as Arcus Biosciences Inc, immunotherapy, cancer, an ATP-adenosine pathway, a key driver, immunosuppression, differentiate small-molecule immuno-oncology product candidate, its product pipeline, Domvanalimab, Etrumadenant, Zimberelimab, clinical trial, different type, Prostate, Lung, Colorectal.
2015
( 11 years old in 2026 )
Arcus Biosciences Inc
-
3928 Point Eden Way
Hayward, CA 94545
United States
Private
Arcus Biosciences Incimmunotherapycanceran ATP-adenosine pathwaya key driverimmunosuppressiondifferentiate small-molecule immuno-oncology product candidateits product pipelineDomvanalimabEtrumadenantZimberelimabclinical trialdifferent typeProstateLungColorectal
* We use standard office opening hours in near Arcus Biosciences's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Arcus Biosciences is Biotechnology business from United States that founded in 2015 (11 years old in 2026), Arcus Biosciences business is focusing on Arcus Biosciences Inc.
Arcus Biosciences headquarter office and corporate office address is located in 3928 Point Eden Way Hayward, CA 94545 United States.
Arcus Biosciences was founded in United States.
In 2026, Arcus Biosciences is currently focus on Arcus Biosciences Inc sector.
Above is snippet of Google Trends for "Arcus Biosciences Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Arcus Biosciences, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
